Language
Madrigal Pharmaceuticals stock jumps on MASH drug hopes

News

HomeHome / News / Madrigal Pharmaceuticals stock jumps on MASH drug hopes
search
RECENT NEWS

Jun 21, 2023

Odyssey Marine Exploration Announces Partnership with Ocean Minerals LLC for a New Cook Islands Exploration Project

Aug 01, 2023

Analysis of the impact of DGAT1 p.M435L and p.K232A variants on pre

Sep 06, 2023

Could ultra

Oct 10, 2023

Sunrise Group among the world's top ten chemical distributors

Oct 14, 2023

Orally Disintegrating Tablet Excipient Market Research Report 2023

SEND YOUR INQUIRY
SUBMIT

Nov 05, 2024

Madrigal Pharmaceuticals stock jumps on MASH drug hopes

Madrigal Pharmaceuticals (MDGL) shares jumped after Novo Nordisk (NVO) announced that a trial showed its weight-loss drug Wegovy helped those with a fatty liver disease called MASH. Madrigal has its

Madrigal Pharmaceuticals (MDGL) shares jumped after Novo Nordisk (NVO) announced that a trial showed its weight-loss drug Wegovy helped those with a fatty liver disease called MASH. Madrigal has its own MASH treatment. Analysts think that the Wegovy news will do a couple of things. First it helps raise awareness of the disease. They also note Madrigal's treatment could address certain issues related to the disease that Wegovy can't.

Market Domination Anchors Julie Hyman and Josh Lipton discuss the news in the video above.

To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

This post was written by Stephanie Mikulich.